Marina Ruiz-Romeo

Ms. Marina Ruiz-Romeo

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2024 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
MRMarina Ruiz-Romeo
Marina Ruiz-Romeo
LCLaura Ciria-Suarez
Laura Ciria-Suarez
JMJoan Carles Medina
Joan Carles Medina
MSMaria Serra-Blasco
Maria Serra-Blasco
ASArnau Souto-Sampera
Arnau Souto-Sampera
COCristian Ochoa-Arnedo
Cristian Ochoa-Arnedo
Objectives: Breast cancer (BC) impacts the patients’ quality of life. Peer support can provide emotional understanding and enhances access to information, social support, coping strategies, and empowerment. Comunitats is an online peer support community app for BC survivors that involves healthcare professionals. This study aims to explore how participation in Comunitats promotes empowerment, and to identify the variables related to it. Methods: A prospective, cross-sectional approach was applied. One hundred twenty-one women diagnosed with BC were included in Comunitats. Sociodemographic and clinical variables, along with measures of emotional distress (HADS), post-traumatic growth (PTGI), and empowerment (Van Uden-Kraan’s Empowerment Questionnaire), were collected through an online questionnaire completed by the participants. Additionally, data on participation in the online community were obtained directly from the app. Assessments were conducted at inclusion and again 3 months later. Correlations were used to guide linear regression analysis to identify the variables predicting greater empowerment outcomes. Results: Empowerment assessment indicated that participants felt empowered by their involvement in Comunitats. The most commonly experienced empowerment outcomes were “being better informed” and “improved acceptance of the illness.” “Exchanging information” and “finding recognition” were the most strongly experienced empowerment processes and the strongest predictors of empowerment outcomes in the regression analysis. Conclusion: Involvement in Comunitats enhances empowerment in BC survivors. Empowering processes within the community partially predict overall empowerment outcomes. Practical implications: Empowerment positively impacts self-care autonomy, self-efficacy, and treatment adherence, promoting healthier lifestyles and enhanced treatment outcomes. Therefore, we recommend encouraging participation in online peer support communities, as it might enhance empowerment.

4 June 2024 in JMIR Formative Research
Verified
Journal Article
Open access
LHLidia Hurtado
Lidia Hurtado
MCMelinda Gonzalez Concepcion
Melinda Gonzalez Concepcion
AFAida Flix-Valle
Aida Flix-Valle
MRMarina Ruiz-Romeo
Marina Ruiz-Romeo
SGSonia Gonzalez-Rodriguez
Sonia Gonzalez-Rodriguez
AMAlberto Mussetti
Alberto Mussetti
Background: Patients with hematological malignancies receiving hematopoietic cell transplantation (HCT) or chimeric antigen receptor (CAR) T-cell therapy are at risk of developing serious clinical complications after discharge. Objective: The aim of the TEL-HEMATO study was to improve our telehealth platform for the follow-up of patients undergoing HCT or CAR T-cell therapy during the first 3 months after discharge with the addition of wearable devices. Methods: Eleven patients who received autologous (n=2) or allogeneic (n=5) HCT or CAR T-cell therapy (n=4) for hematological malignancies were screened from November 2022 to July 2023. Two patients discontinued the study after enrollment. The telehealth platform consisted of the daily collection of vital signs, physical symptoms, and quality of life assessment up to 3 months after hospital discharge. Each patient received a clinically validated smartwatch (ScanWatch) and a digital thermometer, and a dedicated smartphone app was used to collect these data. Daily revision of the data was performed through a web-based platform by a hematologist or a nurse specialized in HCT and CAR T-cell therapy. Results: Vital signs measured through ScanWatch were successfully collected with medium/high adherence: heart rate was recorded in 8/9 (89%) patients, oxygen saturation and daily steps were recorded in 9/9 (100%) patients, and sleeping hours were recorded in 7/9 (78%) patients. However, temperature recorded manually by the patients was associated with lower compliance, which was recorded in 5/9 (55%) patients. Overall, 5/9 (55%) patients reported clinical symptoms in the app. Quality of life assessment was completed by 8/9 (89%) patients at study enrollment, which decreased to 3/9 (33%) at the end of the third month. Usability was considered acceptable through ratings provided on the System Usability Scale. However, technological issues were reported by the patients. Conclusions: While the addition of wearable devices to a telehealth clinical platform could have potentially synergic benefits for HCT and CAR T-cell therapy patient monitoring, noncomplete automation of the platform and the absence of a dedicated telemedicine team still represent major limitations to be overcome. This is especially true in our real-life setting where the target population generally comprises patients of older age with a low digital education level.

1 January 2024 in Digital Health
Verified
Journal Article
Open access
MSMaria Serra-Blasco
Maria Serra-Blasco
ASArnau Souto-Sampera
Arnau Souto-Sampera
JMJoan Carles Medina
Joan Carles Medina
AFAida Flix-Valle
Aida Flix-Valle
LCLaura Ciria-Suarez
Laura Ciria-Suarez
COCristian Ochoa-Arnedo
Cristian Ochoa-Arnedo
Introduction: Breast cancer often leads to cancer-related cognitive impairment (CRCI), which includes both objective and subjective cognitive deficits. While psychosocial interventions benefit quality of life and distress reduction, their impact on cognitive deficits is uncertain. This study evaluates the integration of a cognitive module into a digital psychosocial intervention for breast cancer patients. Methods: In this randomized controlled trial (RCT), 88 recently diagnosed breast cancer (BC) patients will receive the ICOnnecta't program (control group) – a digital stepped intervention addressing a variety of psychosocial needs. The experimental group ( n = 88) will receive ICOnnecta’t plus a cognitive module. Assessments at baseline, 3, 6, and 12 months will measure the interventions’ impact on cognition, emotional distress, medication adherence, quality of life, post-traumatic stress, work functioning and healthcare experience. Feasibility and cost-utility analyses will also be conducted. Results: The cognitive module includes three levels. The first level contains a cognitive screening using FACT-Cog Perceived Cognitive Impairment (PCI). Patients with PCI <54 progress to a cognitive psychoeducational campus (Level 2) with content on cognitive education, behavioural strategies and mindfulness. Patients with persistent or worsened PCI (≥6) after 3 months move to Level 3, an online cognitive training through CogniFit software delivered twice a week over 12 weeks. Conclusions: This study assesses whether integrating a cognitive module into a digital psychosocial intervention improves objective and subjective cognition in breast cancer patients. Secondary outcomes explore cognitive improvement's impact on psychosocial variables. The research will contribute to testing efficacious approaches for detecting and addressing cognitive dysfunction in breast cancer patients. Trial registration: ClinicalTrials.gov, NCT06103318. Registered 26 October 2023, https://classic.clinicaltrials.gov/ct2/show/NCT06103318?term=serra-blasco&draw=2&rank=4

29 December 2023 in JMIR Preprints
Verified
Preprint
Open access
LHLidia Hurtado
Lidia Hurtado
MCMelinda Gonzalez Concepcion
Melinda Gonzalez Concepcion
AFAida Flix-Valle
Aida Flix-Valle
MRMarina Ruiz-Romeo
Marina Ruiz-Romeo
SGSonia Gonzalez-Rodriguez
Sonia Gonzalez-Rodriguez
AMAlberto Mussetti
Alberto Mussetti
BACKGROUND Patients with hematological malignancies receiving hematopoietic cell transplantation (HCT) or chimeric antigen receptor (CAR) T-cell therapy are at risk of developing serious clinical complications after discharge. OBJECTIVE The aim of the TEL-HEMATO study was to improve our telehealth platform for the follow-up of patients undergoing HCT or CAR T-cell therapy during the first 3 months after discharge with the addition of wearable devices. METHODS Eleven patients who received autologous (n=2) or allogeneic (n=5) HCT or CAR T-cell therapy (n=4) for hematological malignancies were screened from November 2022 to July 2023. Two patients discontinued the study after enrollment. The telehealth platform consisted of the daily collection of vital signs, physical symptoms, and quality of life assessment up to 3 months after hospital discharge. Each patient received a clinically validated smartwatch (ScanWatch) and a digital thermometer, and a dedicated smartphone app was used to collect these data. Daily revision of the data was performed through a web-based platform by a hematologist or a nurse specialized in HCT and CAR T-cell therapy. RESULTS Vital signs measured through ScanWatch were successfully collected with medium/high adherence: heart rate was recorded in 8/9 (89%) patients, oxygen saturation and daily steps were recorded in 9/9 (100%) patients, and sleeping hours were recorded in 7/9 (78%) patients. However, temperature recorded manually by the patients was associated with lower compliance, which was recorded in 5/9 (55%) patients. Overall, 5/9 (55%) patients reported clinical symptoms in the app. Quality of life assessment was completed by 8/9 (89%) patients at study enrollment, which decreased to 3/9 (33%) at the end of the third month. Usability was considered acceptable through ratings provided on the System Usability Scale. However, technological issues were reported by the patients. CONCLUSIONS While the addition of wearable devices to a telehealth clinical platform could have potentially synergic benefits for HCT and CAR T-cell therapy patient monitoring, noncomplete automation of the platform and the absence of a dedicated telemedicine team still represent major limitations to be overcome. This is especially true in our real-life setting where the target population generally comprises patients of older age with a low digital education level.

26 December 2023 in Neuroscience Applied
Verified
Journal Article
Open access
MRMarina Ruiz-Romeo
Marina Ruiz-Romeo
JMJoan Carles Medina
Joan Carles Medina
MSM. Serra-Blasco
M. Serra-Blasco
AFAida Flix-Valle
Aida Flix-Valle
ASA. Souto-Sampera
A. Souto-Sampera
COC. Ochoa-Arnedo
C. Ochoa-Arnedo

29 March 2024 in Research Square
Verified
Preprint
Open access
PDF file
MRMarina Ruiz-Romeo
Marina Ruiz-Romeo
LCLaura Ciria-Suarez
Laura Ciria-Suarez
JMJoan C. Medina
Joan C. Medina
MSMaria Serra-Blasco
Maria Serra-Blasco
ASArnau Souto-Sampera
Arnau Souto-Sampera
COCristian Ochoa-Arnedo
Cristian Ochoa-Arnedo
Objectives: Breast cancer (BC) impacts the patient’s quality of life. Peer support can provide emotional understanding as well as enhance information access, social support, and coping strategies, aligning with empowerment. Comunitats is an online peer support community addressed to BC survivors, involving healthcare professionals. This study aims to explore how participation in Comunitats promotes empowerment, and which variables are related to it. Methods: 121 women diagnosed with BC were included in Comunitats. Emotional distress, post-traumatic growth and empowerment were assessed at inclusion and three months later. Correlations were used to guide linear regression analysis to identify which variables are able to predict greater empowerment outcomes. Results: Empowerment assessment indicated that participants felt empowered by their involvement in Comunitats. The empowerment outcomes more commonly experienced were 'being better informed' and 'improved acceptance of the illness'. 'Exchanging information' and 'finding recognition' were the strongest experienced empowerment processes. Conclusion: Involvement in Comunitatsenhances empowerment in BC survivors. Empowering processes within the community partially predict overall empowerment outcomes. Practical Implications: Empowerment positively impacts self-care autonomy, self-efficacy, and treatment adherence, promoting healthier lifestyles and enhanced treatment outcomes.